FLAHARTY ASSET MANAGEMENT, LLC Revance Therapeutics, Inc. Transaction History

FLAHARTY ASSET MANAGEMENT, LLC portfolio value:

$336,000
portfolio value

FLAHARTY ASSET MANAGEMENT, LLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -28.65% -5K shares 95K $27 12.45K
Q2 2022 share Increase +12.94% 2K shares -60K $13.82 17.45K
Q1 2022 share 0.00% 0 shares 49K $19.5 15.45K
Q4 2021 share Increase 0.00% 15.45K shares 252K $16.49 15.45K